Zirgan

Active Ingredient(s): Ganciclovir
FDA Approved: * September 15, 2009
Pharm Company: * SIRION THERAP
Category: Antiviral

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zirgan Overview

Ganciclovir, sold under the brand name Cytovene among others, is an antiviral medication used to treat cytomegalovirus (CMV) infections. Ganciclovir was patented in 1980 and approved for medical use in 1988.[1] Contents 1 Medical use 2 Adverse effects 2.1 Toxicity 3 Mechanism of action 4 Pharmacokinetics 4.1 Administration 5 See also 6 References 7 Further reading 8 External links Medical use Ganciclovir is indicated for:[2] Sight-threatening CMV ...

Read more Zirgan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ganciclovir

Recent Zirgan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ganciclovir
  • Capsule: 250mg, 500mg
  • Gel: 0.15%
  • Implant: 4.5mg
  • Injection: 2mg/ml, 500mg, 500mg/vial
  • Solution: 500mg/250ml (2mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zirgan: (1 result)

Sorted by National Drug Code
  • 24208-535 Zirgan 1.5 mg/g Ophthalmic Gel by Bausch & Lomb Incorporated

Other drugs which contain Ganciclovir or a similar ingredient: (5 results)